Results 221 to 230 of about 75,611 (308)

Estimating the Size of the U.S. Market for New Antibiotics with Activity against Carbapenem-Resistant Enterobacteriaceae [PDF]

, 2019
Cornelius J. Clancy, M. Hong Nguyen
openalex   +1 more source

Outcome and Safety of Colistin Usage in Pediatric Cancer Patients with Carbapenem-Resistant Enterobacteriaceae Bacteremia at Children Cancer Hospital Egypt

, 2023
Nagla Adel, Reham Khedr, Mervat Elanany, Hala F. Zaki, Hanafy Hafez, Hanan S. El‐Abhar   +5 more
openalex   +1 more source

Carbapenem-resistant Enterobacteriaceae : A serious concern in cancer patients

, 2020
Sanjay Biswas, Vivek Bhat, Rohini Kelkar
openalex   +1 more source

Prevalence of Carbapenem-Resistant Enterobacteriaceae in Intensive Care Units in Saudi Arabia: <i>A 10-Year Systematic Review</i>. [PDF]

Saudi Med J
Zakai SA.
europepmc   +1 more source

518. Comparing the Mortality of Carbapenemase-Producing and Non-Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae Bacteremia [PDF]

, 2019
Hyeonji Seo, Eunmi Yang, Seongman Bae, Hyemin Chung, Eunbeen Cho, Sang‐Oh Lee, Sang‐Ho Choi, Yang Soo Kim, Sung‐Han Kim, Jun Hee Woo, Jiwon Jung, Min Jae Kim, Heungsup Sung, Mi‐Na Kim, Sujin Park, Yong Pil Chong   +15 more
openalex   +1 more source

Cost-effectiveness analysis of ceftazidime avibactam versus colistin in carbapenem-resistant enterobacteriaceae in Iran. [PDF]

Cost Eff Resour Alloc, 2023
Goudarzi Z, Danayi F, Keshavarz K, Gholami A.   +3 more
europepmc   +1 more source

631. Laboratory Surveillance of Carbapenem-Resistant Enterobacteriaceae in an Endemic Country, Greece, 2015–2018

, 2019
Kyriaki Tryfinopoulou, Panagiota Giakkoupi, Όλγα Παππά, Kleon Karadimas, Sotirios Tsiodras, Alkiviadis Vatopoulos   +5 more
openalex   +2 more sources

Ceftazidime/avibactam versus standard-of-care agents against carbapenem-resistant Enterobacteriaceae harbouring blaKPC in a one-compartment pharmacokinetic/pharmacodynamic model [PDF]

, 2018
Katie E. Barber, Jason M. Pogue, Henderson D. Warnock, Robert A. Bonomo, Keith S. Kaye   +4 more
openalex   +1 more source

Drug Resistance and Epidemiological Analysis of Carbapenem-Resistant Enterobacteriaceae in a Brain and Psychiatric Hospital of South China. [PDF]

J Clin Lab Anal
Yue L, Zhu X, Kuang Y, Lin Y, Liu H.
europepmc   +1 more source

The Comparative Efficacy of Ceftazidime-Avibactam with or without Aztreonam vs Polymyxins for Carbapenem-resistant Enterobacteriaceae Infections: A Prospective Observational Cohort Study. [PDF]

Indian J Crit Care Med, 2023
Vijayakumar M, Selvam V, Renuka MK, Rajagopalan RE.   +3 more
europepmc   +1 more source